Skip to content
OpenCapital
Get started

Viemed Healthcare, Inc. VMD Cash & Equivalents

Cash & Equivalents at other companies

AdaptHealth logo
AdaptHealthAHCO
$47.96M-10.6%
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
$142.03M-42.4%
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
$4.91M-5.9%
ResMed logo
ResMedRMD
$1.66B+78.0%
UFP Technologies logo
UFP TechnologiesUFPT
$19.98M+42.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$488.08M+23.4%

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$448.16M+71.3%
Enterprise value$450.83M+74.6%
P/E30.1×+8.8×
P/S1.6×+0.4×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%—

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Reported directly by Viemed Healthcare, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viemed Healthcare, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Viemed Healthcare, Inc.'s cash & equivalents?
Viemed Healthcare, Inc. (VMD) reported cash & equivalents of $9.76M in Q1 2026.
How has Viemed Healthcare, Inc.'s cash & equivalents changed year-over-year?
Viemed Healthcare, Inc.'s cash & equivalents decreased by 3.9% year-over-year, from $10.16M to $9.76M.
What is the long-term trend for Viemed Healthcare, Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), Viemed Healthcare, Inc.'s cash & equivalents has grown at a -15.3% compound annual growth rate (CAGR), from $30.98M to $13.5M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.